Laurence Reid Decibel Therapeutics, Inc. (DBTX) insider trading activity

DBTX Quotes by TradingView

Laurence Reid is Director of Decibel Therapeutics, Inc.. Currently has a direct ownership of 0 shares of DBTX, which is worth approximately $0. The most recent transaction as insider was on Sep 25, 2023, when has been sold 220,849 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Laurence Reid Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2023
SELL
Sale (or disposition) back to the issuer
-
220,849 Reduced 100.0%
0 Common Stock
Mar 16 2023
BUY
Grant, award, or other acquisition
-
195,000 Added 46.89%
220,849 Common Stock
Sep 15 2021
BUY
Open market or private purchase
$76,400 $7.64 p/Share
10,000 Added 27.89%
25,849 Common Stock
LR

Laurence Reid

Director
Boston, MA

Track Institutional and Insider Activities on DBTX

Follow Decibel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DBTX shares.

Notify only if

Insider Trading

Get notified when an Decibel Therapeutics, Inc. insider buys or sells DBTX shares.

Notify only if

News

Receive news related to Decibel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DBTX